Advertisement

Journal of Neuro-Oncology

, Volume 100, Issue 2, pp 281–283 | Cite as

Treatment-induced leukoencephalopathy in primary CNS lymphoma presenting as lower body parkinsonism

  • Antonio Milia
  • Giuseppina Pilia
  • Maria Giuseppina Mascia
  • Francesco Maria Manconi
Case Report
  • 118 Downloads

Introduction

Lower body parkinsonism (LBP) is a term coined to identify a relatively homogeneous subgroup of parkinsonism, distinct from idiopathic parkinson’s disease (PD) and characterized by gait difficulty with postural instability, freezing, lack of or minimal upper limb involvement, and poor response to levodopa. Although vascular etiology is highly predominant, LBP had been more rarely associated with other causes such as advanced PD and normal pressure hydrocephalus (NPH). We describe the case of a patient treated with chemoradiotherapy for a primary CNS lymphoma (PCNSL), who several years later presented a clinical picture strongly evocative of LBP. Neuroimaging studies showed diffuse subcortical white matter lesion suggesting radiotherapy-induced leukoencephalopathy. To our knowledge, this is the first case of clinically manifest LBP described in patients who received effective PCNSL therapy.

Case report

A 54-year-old woman, with no history of hypertension, was referred to...

Keywords

Motor Symptom Primary Central Nervous System Lymphoma Postural Instability Normal Pressure Hydrocephalus Normal Pressure Hydrocephalus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    DeAngelis LM (1999) Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy. J Neurooncol 43:249–257CrossRefPubMedGoogle Scholar
  2. 2.
    Abrey LE, Yahalom J, DeAngelis LM (2000) Treatment for primary CNS lymphoma: the next step. J Clin Oncol 18:3144–3150PubMedGoogle Scholar
  3. 3.
    Omuro AM, Ben-Porat LS, Panageas KS, Kim AK et al (2005) Delayed neurotoxicity in primary central nervous system lymphoma. Arch Neurol 62:1595–1600CrossRefPubMedGoogle Scholar
  4. 4.
    Harder H, Holtel H, Bromberg JEC, Poortmans P (2004) Cognitive status and quality of life after treatment for primary CNS lymphoma. Neurology 62:544–547PubMedGoogle Scholar
  5. 5.
    Fitzgerald PM, Jankovic J (1989) Lower body parkinsonism: evidence for vascular etiology. Mov Disord 4:249–260CrossRefPubMedGoogle Scholar
  6. 6.
    Lai R, Abrey LE, Rosenblum MK, DeAngelis LM (2004) Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study. Neurology 62:451–456PubMedGoogle Scholar
  7. 7.
    Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC (2002) Subcortical ischaemic vascular dementia. Lancet Neurol 1:426–436CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2010

Authors and Affiliations

  • Antonio Milia
    • 1
  • Giuseppina Pilia
    • 1
  • Maria Giuseppina Mascia
    • 1
  • Francesco Maria Manconi
    • 1
  1. 1.UO Neurologia Riabilitativa Ospedale Santissima Trinità CagliariCagliariItaly

Personalised recommendations